LivaNova (LIVN) Net Margin Growth (3y) (2019 - 2026)

LivaNova (LIVN) Net Margin Growth (3y) (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Abbott Laboratories 181.32 Bn 174.03 Bn 6.27 Bn -388.00
2 Stryker 128.59 Bn 125.71 Bn 3.81 Bn -1.00
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn -108.00
4 Boston Scientific 67.77 Bn 66.32 Bn 3.61 Bn 1,692.00
5 Edwards Lifesciences 48.13 Bn 44.46 Bn 1.29 Bn -
6 GE HealthCare Technologies 28.44 Bn 26.15 Bn 1.98 Bn 399.00
7 Dexcom 28.41 Bn 27.29 Bn 750.30 Mn 1,018.00
8 Smith & Nephew 26.77 Bn 26.20 Bn - -
9 Koninklijke Philips 25.24 Bn 22.11 Bn 2.07 Bn 1,978.00
10 LivaNova 4.35 Bn 3.81 Bn 243.75 Mn 358.00

Historic Data

Download Data
DateValue
Mar 31, 2026 358.00
Dec 31, 2025 795.00
Sep 30, 2025 5,001.00
Jun 30, 2025 122.00
Mar 31, 2025 -10,456.00
Dec 31, 2023 546.00
Mar 31, 2023 322.00
Dec 31, 2022 55.00
Jun 30, 2022 642.00
Dec 31, 2020 2,864.00
Mar 31, 2020 45.00
Dec 31, 2019 948.00
Jun 30, 2019 157.00